VANCOUVER, British Columbia--(BUSINESS WIRE)--In response to a mandate from the board of directors and senior management of ProtoKinetix, Inc. (OTCBB: PKTX), Edward D. Martin, M.D., Chairman of its Business Advisory Board, has outlined his priorities and strategy for business development. “Our number one priority is to engage a big Health Care partner to advance our cell technology and to maximize the many commercial applications that exist,” Dr. Martin commented. “We are involved in active dialogue with prospective partners and are confident that our discussions will result in meaningful partnerships,” Martin said.
